Marketing-authorisation holder
Denk Pharma GmbH & Co. KG
26 medicines in 1 country, as authorisation holder and manufacturer.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 26
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 26 | 26 | 0 | CompaniesAll medicines |
Also in the registers of Singapore
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Antithrombotic agentsBlood and blood-forming organs · ATC B01A
- Antineoplastic agentsAntineoplastic and immunomodulating agents · ATC L01E
- Agents acting on the renin–angiotensin systemCardiovascular system · ATC C09B
- Lipid-modifying agentsCardiovascular system · ATC C10A
- Lipid-modifying agentsCardiovascular system · ATC C10B
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- denk
- denk pharma gmbh co kg
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 26
- Countries
- 1
- Roles
- Authorisation holder and manufacturer